» Authors » H Allgayer

H Allgayer

Explore the profile of H Allgayer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 93
Citations 2124
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Schmaus A, Klusmeier S, Rothley M, Dimmler A, Sipos B, Faller G, et al.
Br J Cancer . 2014 Jun; 111(3):559-67. PMID: 24937668
Background: Association studies have implicated the glycosaminoglycan hyaluronan (hyaluronic acid, HA) and its degrading enzymes the hyaluronidases in tumour progression and metastasis. Oligosaccharides of degraded HA have been ascribed a...
2.
Jeltsch K, Radke T, Laufs S, Giordano F, Allgayer H, Wenz F, et al.
J Stem Cells Regen Med . 2014 Apr; 6(2):113-4. PMID: 24693127
No abstract available.
3.
Schildberg C, Abbas M, Merkel S, Agaimy A, Dimmler A, Schlabrakowski A, et al.
J Surg Oncol . 2013 Sep; 108(6):409-13. PMID: 24037722
Background And Objectives: Despite its dwindling occurrence, gastric cancer remains a leading cause of cancer related mortality worldwide. Molecular determinants of prognosis that impact survival are being sought out as...
4.
Allgayer H, Ignee A, Zipse S, Crispin A, Dietrich C
Z Gastroenterol . 2012 Dec; 50(12):1281-6. PMID: 23225555
Background And Aims: Transanal real-time elastography (RTE) was demonstrated to yield valuable information regarding elastic properties of the anal sphincter in patients with fecal incontinence. We studied the role of...
5.
Maier P, Heckmann D, Spier I, Laufs S, Zucknick M, Allgayer H, et al.
Cancer Gene Ther . 2012 Oct; 19(11):802-10. PMID: 23037811
Chemoprotection of haematopoietic stem cells (HSCs) by gene therapeutic transfer of drug-resistance genes represents the encouraging approach to prevent myelosuppression, which is one of the most severe side effects in...
6.
Patil N, Abba M, Hodl P, Schwarzbach M, Allgayer H
Adv Med Sci . 2012 May; 57(1):37-45. PMID: 22543255
Purpose: Histology still forms the backbone for the diagnosis of the myxoid and round cell subtypes of liposarcoma but the molecular identification of the different transcript variants remains a challenge,...
7.
Nagel J, Bucker S, Wood M, Stark R, Goke B, Parhofer K, et al.
Exp Clin Endocrinol Diabetes . 2012 Jan; 120(4):224-8. PMID: 22231920
Introduction: Epidemiological studies have found an increased risk for colon cancer and faster disease progression in patients with type 2 diabetes mellitus (T2DM). We aimed to determine whether patients with...
8.
Keklikoglou I, Koerner C, Schmidt C, Zhang J, Heckmann D, Shavinskaya A, et al.
Oncogene . 2011 Dec; 31(37):4150-63. PMID: 22158050
MicroRNAs (miRNAs) as modulators of gene expression have been described to display both tumor-promoting and tumor-suppressive functions. Although their role has been studied in different tumor types, little is known...
9.
Mudduluru G, Ceppi P, Kumarswamy R, Scagliotti G, Papotti M, Allgayer H
Oncogene . 2011 Feb; 30(25):2888-99. PMID: 21317930
Axl is a receptor that induces proliferation, migration and invasion in cancer. In this study, we show that specific microRNAs (miRNAs) target the 3'-UTR of Axl. Luciferase-reporter assays with wild-type...
10.
Korner A, Mudduluru G, Manegold C, Allgayer H
Br J Cancer . 2010 Aug; 103(6):802-11. PMID: 20736951
Background: Enzastaurin (Enz) is a serine/threonine kinase inhibitor blocking protein kinase C (PKC)beta/AKT pathway. However, an ability of this compound to inhibit cancer invasion and metastasis is not yet clearly...